Ep. 538 Immunotherapy and TACE in HCC Treatment with Dr. Julius Chapiro and Dr. Richard Finn

Ep. 538 Immunotherapy and TACE in HCC Treatment with Dr. Julius Chapiro and Dr. Richard Finn

There are now multiple phase 3 studies on combination transarterial chemoembolization (TACE) and immunotherapy showing a significant benefit over TACE alone. How do these findings change the hepatocellular carcinoma (HCC) treatment algorithm? In this multidisciplinary episode of the BackTable Podcast, Dr. Richard Finn (Medical Oncologist at UCLA) and Dr. Julius Chapiro (Interventional Radiologist at Yale University) join host Dr. Chris Beck to discuss immunotherapy, TACE, emerging trends in HCC treatment, and the future of the field.---This podcast is supported by an educational grant from Guerbet.---SYNPOSISThe doctors highlight the importance of high quality clinical data and the pivotal studies shaping current best practices. They explore the role of the different players on the multidisciplinary team and compare the oncologic and radiologic perspectives. Additionally, they discuss the synergy between TACE and immunotherapy, the criteria for selecting appropriate treatments, and the ongoing need for research and collaboration.---TIMESTAMPS00:00 - Introduction 03:35 - HCC from an Oncologic Perspective 05:33 - Radiological Perspective on Liver Cancer06:50 - Referral Patterns and Organizing a Multidisciplinary Approach18:01 - Explaining TACE and Variations in the Procedure27:27 - Choosing the Right Procedure for HCC36:13 - Making a Decision on Medical Treatment Candidacy 42:23 - Importance of Data Driven HCC Treatment, Practical Insights, and Studies to Know55:30 - Planning an Approach for a TACE Procedure01:02:26 - Final Thoughts and Future Prospects in Liver Cancer Treatment---RESOURCESBarcelona Staging System:https://www.ncbi.nlm.nih.gov/books/NBK569796/table/Ch3-t0001/TRACE Trial:https://pubs.rsna.org/doi/full/10.1148/radiol.211806PREMIERE Trial:https://www.gastrojournal.org/article/S0016-5085(16)34971-X/fulltextEMERALD-1 Trial:https://ascopubs.org/doi/10.1200/JCO.2024.42.3_suppl.LBA432LEAP O12 Study:https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02575-3/abstract

Avsnitt(640)

Ep. 603 Biopsy and Ablation Decision-Making in Lung Cancer with Dr. Alan Lee, Dr. Scott Oh, Dr. Rob Suh

Ep. 603 Biopsy and Ablation Decision-Making in Lung Cancer with Dr. Alan Lee, Dr. Scott Oh, Dr. Rob Suh

Why might simultaneous ablation and biopsy be the new standard for high-probability lung cancer cases where surgery isn’t an option? In the penultimate episode of the 2025 NSCLC Creator Weekend™ serie...

2 Jan 40min

Ep. 602 Managing Neuroendocrine Tumors in Interventional Radiology with Dr. Daniel DePietro

Ep. 602 Managing Neuroendocrine Tumors in Interventional Radiology with Dr. Daniel DePietro

What considerations drive your decision between bland embolization, TACE, and radioembolization in managing neuroendocrine tumors? In this BackTable episode, Dr. Daniel DePietro, interventional radiol...

30 Dec 20251h 23min

Ep. 601 Revenue Cycle Management: Key Strategies for Healthcare Success with Laurie Bouzarelos MHA, CPC, FACHE

Ep. 601 Revenue Cycle Management: Key Strategies for Healthcare Success with Laurie Bouzarelos MHA, CPC, FACHE

The ultimate challenge of operating an OBL is staying profitable. In this episode of BackTable, we bring on healthcare administrator Laurie Bouzarelos and interventional radiologist Dr. Mary Costantin...

26 Dec 20251h 42min

Ep. 600 Exploring Artificial Intelligence Utility in Endovascular Procedures with Dr. Emil Cohen

Ep. 600 Exploring Artificial Intelligence Utility in Endovascular Procedures with Dr. Emil Cohen

OpenEvidence was founded in 2022. In just 3 short years, it has become a household name amongst aspiring and established healthcare providers. AI-based tools are now being used to augment workflows, i...

23 Dec 202558min

Ep. 599 Lung Ablation: Techniques, Challenges, & Best Practices with Dr. Alan Lee, Dr. Scott Oh, and Dr. Rob Suh

Ep. 599 Lung Ablation: Techniques, Challenges, & Best Practices with Dr. Alan Lee, Dr. Scott Oh, and Dr. Rob Suh

Collaboration between interventional radiology and radiation oncology has enabled high-dose brachytherapy in central lung lesions that were previously untreatable. This episode of the 2025 NSCLC Creat...

19 Dec 202540min

 Ep. 598 Genicular Artery Embolization: Insights & Techniques with Dr. Rachel Piechowiak and Dr. Faraz Khan

Ep. 598 Genicular Artery Embolization: Insights & Techniques with Dr. Rachel Piechowiak and Dr. Faraz Khan

How is genicular artery embolization reshaping our clinical approach to patients with chronic knee pain? Dr. Rachel Piechowiak and Dr. Faraz Khan, interventional radiologists at IR Centers join Dr. D...

16 Dec 202558min

Ep. 597 Ablative Treatments & Radiotherapy: The Latest in Lung Cancer Treatment with Dr. Alan Lee, Dr. Scott Oh, and Dr. Rob Suh

Ep. 597 Ablative Treatments & Radiotherapy: The Latest in Lung Cancer Treatment with Dr. Alan Lee, Dr. Scott Oh, and Dr. Rob Suh

Why might the standard RECIST criteria fail to accurately track success after tumor ablation, and what should you look for instead? In the 4th installment of the 2025 NSCLC Creator Weekend™ series, ho...

12 Dec 20251h 10min

Ep. 596 Thrombin Injection for Pseudoaneurysms: Technique & Considerations with Dr. Gabriel Werder

Ep. 596 Thrombin Injection for Pseudoaneurysms: Technique & Considerations with Dr. Gabriel Werder

Pseudoaneurysms are among the most common complications of vascular access. Here’s a refresher on how to treat them with thrombin injection featuring interventional radiologist Dr. Gabriel Werder from...

9 Dec 202533min

Populärt inom Utbildning

rss-bara-en-till-om-missbruk-medberoende-2
historiepodden-se
det-skaver
alska-oss
harrisons-dramatiska-historia
nu-blir-det-historia
roda-vita-rosen
johannes-hansen-podcast
allt-du-velat-veta
sektledare
rss-viktmedicinpodden
not-fanny-anymore
i-vantan-pa-katastrofen
sa-in-i-sjalen
rss-max-tant-med-max-villman
rss-basta-livet
rss-sjalsligt-avkladd
sex-pa-riktigt-med-marika-smith
rss-pa-insidan-med-bjorn-rudman
rss-ar-det-rimligt